# P2.10 — Cases D/E: Primary-Evidence Stress Tests

Status: ACTIVE — CASE COVERAGE EXPANDED
Provenance: case facts anchored to primary/official public sources; framework mappings are synthesis and require final source-note packaging before Podcast Ready.

## Purpose

Add the two missing stress-test categories identified in the initial P2.10 pack:

1. a production-ramp/capacity case with strong primary evidence;
2. a regulated supplier/quality-system case with official evidence.

These cases are selected to test the backbone, not to assign blame.

---

# Case D — Tesla Model 3 production ramp (2017–2018)

## Why this case

Tesla's SEC filings provide unusually direct primary evidence about:
- high-volume ramp uncertainty;
- bottlenecks and moving constraints;
- automation introduced faster than selected processes could be stabilized;
- temporary return to semi-automated/manual work;
- supplier/manufacturing-system dependencies;
- staged capacity investment;
- the distinction between hitting a weekly rate and sustaining/scaling a production system.

## Primary evidence anchors

Tesla's 2017 Q3 filing states that Model 3 output was below expectations because manufacturing subsystems took longer than expected to bring online. The battery-module assembly line was identified as the primary constraint, and Tesla reported taking over and redesigning key elements originally handled by manufacturing-system suppliers.

Tesla's 2017 annual filing again identified the battery-module assembly line as the primary production constraint and explicitly warned that prior ramp experience demonstrated the difficulty of accurately forecasting production rates at specific points in time. It also described a staged strategy in which capacity for 10,000 vehicles/week would be implemented after achieving the 5,000/week run rate.

Tesla's 2018 Q1 filing states that automation had been added too quickly in certain processes. The company temporarily reduced automation and introduced semi-automated or manual processes in selected battery-module, material-flow and general-assembly operations while correcting the ramp.

Tesla's 2018 Q2 filing states that more than 5,000 Model 3 vehicles were produced in the last week of June and that roughly 5,000/week was repeated multiple times in July, while also noting that additional capacity and supplier ramp were still required for higher sustained rates.

Primary source packet for final packaging:
- Tesla 2017 Q3 Form 10-Q, SEC filing.
- Tesla 2017 Form 10-K, SEC filing.
- Tesla 2018 Q1 Form 10-Q, SEC filing.
- Tesla 2018 Q2 Form 10-Q, SEC filing.

## P2.04 — Capacity / Run-at-Rate stress test

Very strong fit.

The case validates several canonical distinctions already in the backbone:

> A production target is not demonstrated capacity.

> A short peak-rate achievement is not automatically sustained production capability.

> System throughput is governed by the active constraint, and the constraint can move as the system changes.

The public record shows a sequence in which a battery-module process constrained output, corrective work increased capability, and other constraints then required attention.

### Framework result

RAMP 10 survives.

However, the case suggests one explicit addition:

## MOVING CONSTRAINT LOOP

Constraint identification → intervention → local capacity increase → system re-observation → next constraint → rebalancing → sustained-system-rate evidence.

Do not freeze a bottleneck map as if it were a permanent property of the factory.

## P2.07 — Automation stress test

Extremely strong fit.

The case directly supports the Automation Ladder logic:

Manual → Fixture/Poka-Yoke → Assisted → Semi-Automatic → Automatic

is not a maturity ladder in which moving right is always better.

Tesla publicly disclosed that selected processes had been automated too quickly and that semi-automated/manual processes were temporarily introduced while the automated processes were improved.

### Framework result

AUTOMATE 10 survives strongly.

The case reinforces:

> Automation level is an engineering decision, not a maturity score.

And:

> A simpler production method that is stable, diagnosable and recoverable can be superior during ramp to a more automated process that has not earned its production evidence.

## P2.05 — Economics stress test

Strong fit.

Tesla described staging additional capacity after a lower production run rate was achieved, explicitly connecting automation evolution and capital efficiency.

This supports the existing economics principle:

> Do not automate the forecast. Automate the constraint after the evidence earns the investment.

The case also highlights option value: a staged investment preserves learning before the next capital commitment.

### Proposed refinement — STAGED CAPEX OPTION

When uncertainty is high, compare not only A versus B today, but:

Invest now
vs.
Stage investment → learn → update constraint/demand/yield evidence → invest later if justified.

The value of learning and delayed commitment belongs in the decision, even if a simple steady-state unit-cost model ignores it.

## P2.06 — Supplier industrialization stress test

Moderate-to-strong fit.

The 2017 Q3 filing described key elements of battery-module manufacturing zones originally performed by manufacturing-system suppliers that Tesla then took over and significantly redesigned.

This expands supplier thinking beyond purchased product parts:

> Equipment integrators and manufacturing-system suppliers can be production-critical suppliers too.

### Proposed refinement — INDUSTRIALIZATION SUPPLIER

Supplier qualification logic should explicitly include suppliers of:
- production equipment;
- automation cells;
- fixtures/tooling;
- test systems;
- manufacturing software/integration;
when their deliverables determine production capability or quality evidence.

## P2.03 — Quality stress test

The case does not provide enough public detail to use it as a detailed PFMEA/MSA/SPC case, so do not overclaim.

Its legitimate contribution is narrower: rate improvements cannot be treated as successful if quality is not maintained. Final episode packaging should use only claims supported by the relevant filing or additional primary evidence.

## Case D conclusion

Existing backbone explains the case well.

Additions earned by the stress test:
1. MOVING CONSTRAINT LOOP;
2. STAGED CAPEX OPTION;
3. INDUSTRIALIZATION SUPPLIER as an explicit supplier category.

---

# Case E — FDA medical-device quality-system findings: Bioptimal International (2024)

## Why this case

FDA Warning Letter 678281 provides official regulatory evidence of a quality-system failure pattern that is highly relevant to hardware startups transitioning into controlled production:
- complaint/quality data existed;
- recurring or lot-linked signals were present;
- corrective action follow-through was inadequate;
- effectiveness verification/validation was not consistently demonstrated;
- observed failure occurrence could exceed assumptions in the risk-management file without adequate corrective response.

This is not used to generalize all medical-device requirements to other industries. It is used to stress-test our generic quality/evidence frameworks against a regulated system where the expected control loop is explicit.

## Official evidence anchor

FDA's April 3, 2024 Warning Letter to Bioptimal International states, among other findings, that the firm's CAPA procedures did not consistently demonstrate evidence of completed corrective actions or effectiveness verification/validation after corrective action. FDA also described instances where two or more complaints from the same lot with similar failure modes/device malfunctions were not investigated further, and cases where actual occurrence rates for several failure modes exceeded anticipated rates in the risk-management file without corrective action being taken.

Primary source packet:
- FDA Warning Letter 678281, April 3, 2024.

## P2.03 — Quality Chain stress test

Extremely strong fit.

The case validates the closed loop already built:

Signal → Containment → Investigation → Corrective action → PFMEA/risk update → Control update → Effectiveness verification → Learning.

The critical insight is that CAPA is not closed because an action was assigned or implemented.

> Action completed ≠ corrective action demonstrated effective.

### Proposed refinement — EFFECTIVENESS EVIDENCE

Every material corrective action should define before closure:
- the failure/risk signal being changed;
- the expected measurable effect;
- the population/time window used to evaluate it;
- acceptance criteria;
- who owns the review;
- what happens if the signal does not improve.

This is a generic framework synthesis. Industry-specific regulatory requirements must be cited separately.

## FIELD EVIDENCE LOOP stress test

Very strong fit.

The case supports the addition discovered from the Note7 stress test:

Production release → Field population → Complaint/return signal → Population segmentation → Investigation → Corrective configuration/process → Revalidation → Field effectiveness monitoring.

A quality system that sees field signals but cannot aggregate, segment and escalate them has broken the evidence loop.

### Proposed refinement — SIGNAL AGGREGATION

A single complaint may be weak evidence. Multiple events sharing lot, configuration, failure mode, supplier, time window or use condition can create a stronger signal.

Therefore Atlas/Quality logic should support:

Event → classification → population attributes → trend/cluster detection → escalation threshold → investigation.

Do not let each complaint remain an isolated record when the engineering question is population-level.

## P2.08 — Manufacturing Atlas stress test

Strong fit.

To investigate repeated complaints from a lot or configuration, the organization needs to reconstruct:
- affected lot/serial population;
- as-built configuration;
- supplier/material lots;
- process/test history;
- deviations/rework;
- field complaint/return history;
- corrective-action effectivity.

This reinforces TRACE 10 and RECONSTRUCT 8.

### Atlas addition — FIELD EVENT object

Minimum useful links:
FIELD_EVENT
→ product serial/lot where known
→ product/configuration/effectivity
→ complaint/failure classification
→ date/use context
→ investigation/CAPA/NCR
→ returned-unit analysis/evidence
→ corrective action
→ effectiveness-monitoring population.

This does not require a full enterprise QMS in DEV. It requires preserving the engineering truth needed to detect patterns.

## P2.01 — DEV/LVP/SVP stress test

Strong fit with an important guardrail.

Early-stage teams often tolerate informal issue tracking because populations are tiny and engineers personally know every unit. That mechanism fails as volume grows.

DEV:
- preserve prototype/field failures and configuration identity.

LVP:
- classify recurring failures;
- connect lot/serial/configuration;
- define escalation and corrective-action ownership.

SVP:
- systematic trend detection;
- formal effectiveness monitoring;
- scalable complaint/return/CAPA integration appropriate to the applicable regulatory/quality system.

The exact regulatory obligations depend on product/domain/jurisdiction.

## P2.06 — Supplier stress test

Conditional fit.

Lot-linked complaint patterns may implicate supplier/material/process populations, but chronology or clustering alone does not prove supplier causation.

Guardrail:

> Population correlation is an investigation trigger, not proof of root cause.

This should be retained in supplier scorecard and corrective-action language.

## Case E conclusion

The Quality Chain survives strongly, but the case earns three explicit refinements:
1. EFFECTIVENESS EVIDENCE;
2. SIGNAL AGGREGATION;
3. FIELD EVENT as a first-class Atlas object/linkage.

---

# Cross-case stress test — D/E versus existing backbone

| Backbone element | Tesla Model 3 | FDA Bioptimal |
|---|---|---|
| DEV/LVP/SVP maturity | Strong | Strong |
| Configuration/effectivity | Moderate | Strong |
| Quality Chain | Limited public detail | Very strong |
| Capacity/RAMP 10 | Very strong | Low |
| Economics/ECON 10 | Strong | Low |
| Supplier industrialization | Strong for equipment/system suppliers | Conditional |
| Automation/AUTOMATE 10 | Very strong | Low |
| Atlas/TRACE 10 | Moderate | Very strong |
| Field Evidence Loop | Low | Very strong |
| Change/requalification | Strong | Strong |

## New concepts earned across Cases A–E

The complete P2.10 stress test has now exposed or strengthened:

1. FIELD EVIDENCE LOOP;
2. MINIMUM CONTROLLED PRODUCTION MODE;
3. INTERACTION CLAIM;
4. MOVING CONSTRAINT LOOP;
5. STAGED CAPEX OPTION;
6. INDUSTRIALIZATION SUPPLIER;
7. EFFECTIVENESS EVIDENCE;
8. SIGNAL AGGREGATION;
9. FIELD EVENT as an Atlas object.

These are not nine new independent systems. They are targeted repairs/cross-links to the existing backbone.

## Backbone repair map

Before V1 freeze:

P2.03 Quality
- add FIELD EVIDENCE LOOP;
- add EFFECTIVENESS EVIDENCE;
- add SIGNAL AGGREGATION.

P2.04 Capacity
- add MOVING CONSTRAINT LOOP;
- reinforce peak rate versus sustained/system rate.

P2.05 Economics
- add STAGED CAPEX OPTION.

P2.06 Supplier
- add INDUSTRIALIZATION SUPPLIER category;
- retain correlation-versus-causation guardrail.

P2.08 Atlas
- add FIELD EVENT object and field-population linkages.

P2.09 OT Security
- add MINIMUM CONTROLLED PRODUCTION MODE explicitly.

Cross-framework P2.02/P2.03/P2.07
- add INTERACTION CLAIM.

## P2.10 status after Cases D/E

Case-category coverage is now sufficient for the planned V1 stress test:
- supplier/product quality and field recall;
- cyber/operational recovery;
- complex system interaction;
- production ramp/automation/capacity;
- regulated quality-system/field-signal effectiveness.

P2.10 should remain ACTIVE until:
1. the nine earned repairs are applied to the canonical packs;
2. source packets are normalized to the repository provenance method;
3. a cross-framework contradiction audit is completed;
4. unresolved normative claims are explicitly listed.

Recommended next action:

> Apply the case-study-earned repairs, then run the Pass-2 cross-framework contradiction audit before Knowledge Backbone V1 freeze.
